Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.55 |
| ▸ | PGD | P52209 | 3/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4083999 | 1.00 | MPI (0.55) | MPIPGDPGK1PGK2LPAR2 | |
| SCHEMBL13176693 | 0.83 | MPI (0.46) | MPIPGDPGK1PGK2LPAR2 | |
| SCHEMBL18341413 | 0.82 | PGD (0.67) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL18341350 | 0.82 | PGD (0.67) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL20857032 | 0.82 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL139868 | 0.82 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL4594608 | 0.82 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL2234036 | 0.80 | MPI (0.60) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL17923950 | 0.79 | MPI (0.44) | MPIPGDPGK1PGK2LPAR2 | |
| Acetaldehyde SCHEMBL22264056 | 0.77 | MPI (0.56) | MPIPGDPGK1PGK2LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3442992-B1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | MARS INC (US) | 2024-04-10 | — | — | EP | claimed |
| US-20190170772-A1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | MARS, INCORPORATED (US) | 2019-06-06 | — | — | US | claimed |
| EP-3442992-B1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | MARS INC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-3949759-A1 | DEVICES AND METHODS FOR THE PREPARATION OF A NUTRITIONAL FORMULA | Alcresta Therapeutics, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11237177-B2 | Methods for identifying modulators of GPR92 | MARS, INCORPORATED (US) | 2022-02-01 | — | — | US | disclosed |
| US-20210315244-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2021-10-14 | — | — | US | disclosed |
| EP-3846640-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars Incorporated (US) | 2021-07-14 | — | — | EP | disclosed |
| US-20190170772-A1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | MARS, INCORPORATED (US) | 2019-06-06 | — | — | US | disclosed |
| US-20190075830-A1 | DEVICES AND METHODS FOR THE PREPARATION OF A NUTRITIONAL FORMULA | ALCRESTA THERAPEUTICS, INC. (US) | 2019-03-14 | — | — | US | disclosed |
| EP-3442992-A1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | Mars, Incorporated (US) | 2019-02-20 | — | — | EP | disclosed |
| CN-109071608-A | The method for identifying GPR92 regulator | 马斯公司 | 2018-12-21 | — | — | CN | disclosed |
| WO-2017181008-A1 | METHODS FOR IDENTIFYING MODULATORS OF GPR92 | MARS, INCORPORATED (US) | 2017-10-19 | — | — | WO | disclosed |
| EP-1613298-A4 | LYSOPHOSPHATIDIC ACID ANALOGS AND INHIBITION OF NEOINTIMA FORMATION | UNIV TENNESSEE RES FOUNDATION (US) | 2007-10-03 | — | — | EP | disclosed |
| EP-1613298-A2 | LYSOPHOSPHATIDIC ACID ANALOGS AND INHIBITION OF NEOINTIMA FORMATION | The University of Tennessee Research Foundation (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004091496-A2 | LYSOPHOSPHATIDIC ACID ANALOGS AND INHIBITION OF NEOINTIMA FORMATION | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-10-28 | — | — | WO | disclosed |
| US-20040204383-A1 | Lysophosphatidic acid analogs and inhibition of neointima formation | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2004-10-14 | — | — | US | disclosed |